🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1/2 study of the combination of Ad-p53 administered intra-a...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2018-11-20
Trial ID
NCT02842125
This study consists of Part A for monotherapy and Part B for combination th...
Status
Recruiting
Location
NEXT Oncology
Start Date
2021-12-02
Trial ID
NCT05204862
Treatments Being Tested
This is an open-label, multicenter, Phase Ib, dose-escalation and cohort-ex...
Status
Completed
Location
UCLA
Start Date
2012-08-13
Trial ID
NCT01656642
Treatments Being Tested
This study aims to observe and evaluate the efficacy and safety of the peri...
Status
Terminated
Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2020-12-26
Trial ID
NCT04653389
Treatments Being Tested
This trial is the cohort C part of a multicenter, open label Phase Ib/II cl...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2025-04-11
Trial ID
NCT06821503
This is a multicenter, open-label, phase II clinical study conducted in Chi...
Status
Completed
Location
Hunan Cancer Hospital
Start Date
2021-04-01
Trial ID
NCT04868708
Treatments Being Tested
Recent studies suggest that patients with metastatic melanoma whose gut mic...
Status
Completed
Location
Ambroise Paré
Start Date
2022-01-20
Trial ID
NCT04988841
Treatments Being Tested
This is a first-in-human (FIH) study to evaluate the safety and tolerabilit...
Status
Recruiting
Location
University of California San Diego
Start Date
2021-08-18
Trial ID
NCT05007782
Treatments Being Tested
This is a Phase 1/2 study of HST-1011, a CBL-B inhibitor, being developed f...
Status
Active Not Recruiting
Location
Florida Cancer Specialists
Start Date
2023-03-15
Trial ID
NCT05662397
Treatments Being Tested
This is a phase II clinical study evaluating the safety, tolerability, phar...
Status
Recruiting
Location
SunYat-sen University Cancer Center
Start Date
2026-07-10
Trial ID
NCT07669779
Treatments Being Tested